ATP2C1 and neoplasm: Tumor sections stained with antibodies against vascular endothelial growth factor (VEGF), exhibited significantly less stained cells in the Ang-(1-7)-treated group compared with the two control groups, suggesting that Ang-(1-7) reduces Spc-A1 xenograft tumor cell angiogenesis (Figure 8A).